InvestorsHub Logo
Followers 23
Posts 1671
Boards Moderated 0
Alias Born 09/04/2009

Re: None

Tuesday, 01/17/2017 2:03:15 PM

Tuesday, January 17, 2017 2:03:15 PM

Post# of 73424
Viaderma Inc is exploring the possibility of licensing the technology to other pharmaceutical companies. It has products in development in various fields, including topical antibiotics (TetraStem), topical anti-viral product (Viralcur) for genital herpes, anti-fungal products for onychomycocis (OnyPro), hair loss prevention product (HairGain), skin cancer therapies (Cantrile), and a topical stem cell therapy product (TetraStem Plus).

$VDRM